| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037
The effectiveness of protection conferred by CD8+ memory T cells is determined by both their quality and their quantity, which suggests that vaccine efficacy might be improved if it were possible to increase the size of the memory pool. Approximately 90% of virus-specific CD8+ T cells die during the contraction phase and, herein, we have attempted to increase the memory pool by reducing CD8+ T cell death. CD8+ T cell contraction has been attributed to apoptosis, or programmed cell death (PCD), which, classically, is dependent on caspases. Caspase-dependent PCD can be prevented by the pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp (OMe)-fluoromethylketone (zVAD), and here we evaluate the effect of this compound on virus-specific T cell responses in mice. zVAD prevented caspase-dependent PCD of freshly isolated virus-specific T cells in tissue culture, and a fluorescent analog, FITC-VAD, entered CD8+ T cells following in vivo injection. However, despite using 11 different regimens of zVAD administration in vivo, no significant effects on CD8+ or CD4+ memory T cell numbers were observed. Furthermore, the CD8+ memory T cell responses to secondary virus infection were indistinguishable, both qualitatively and quantitatively, in zVAD-treated and normal mice. The absence of effect cannot be attributed to a technical flaw, because identical doses of zVAD were able to rescue mice from hepatocyte apoptosis and lethal intrahepatic hemorrhage, induced by inoculation of anti-Fas Ab. We conclude that the contraction phase of the virus-specific T cell response is unlikely to require caspase-dependent PCD. We propose that contraction can be mediated by an alternative, caspase-independent pathway(s).
This article has been cited by other articles:
|
|
 |
|
  D. Purushothaman and A. Sarin Cytokine-dependent regulation of NADPH oxidase activity and the consequences for activated T cell homeostasis J. Exp. Med., July 6, 2009; 206(7): 1515 - 1523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Prlic and M. J. Bevan Exploring regulatory mechanisms of CD8+ T cell contraction PNAS, October 28, 2008; 105(43): 16689 - 16694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Srivastava, H. Banerjee, A. Chaudhry, A. Khare, A. Sarin, A. George, V. Bal, J. M. Durdik, and S. Rath Apoptosis-Inducing Factor Regulates Death in Peripheral T Cells J. Immunol., July 15, 2007; 179(2): 797 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mehrotra, A. Chhabra, U. Hegde, N. G. Chakraborty, and B. Mukherji Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death J. Leukoc. Biol., February 1, 2007; 81(2): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Grayson, A. E. Weant, B. C. Holbrook, and D. Hildeman Role of Bim in Regulating CD8+ T-Cell Responses during Chronic Viral Infection. J. Virol., September 1, 2006; 80(17): 8627 - 8638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Sercan, G. J. Hammerling, B. Arnold, and T. Schuler Cutting Edge: Innate Immune Cells Contribute to the IFN-{gamma}-Dependent Regulation of Antigen-Specific CD8+ T Cell Homeostasis J. Immunol., January 15, 2006; 176(2): 735 - 739. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
